Combining Immunotherapy with Radiation Therapy in Non-Small Cell Lung Cancer.
02/03/2020
/
Publications
/
Immunotherapy
As immunotherapy, especially the immune checkpoint inhibitors have recently been demonstrated to improve survival in metastatic and locally advanced non-small...
Abscopal Effect Followiing PBRT in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma.
09/09/2019
/
Publications
/
Immunotherapy
The first case report of an abscopal effect in a patient of retroperitoneal sarcomas (RPS) treated with proton therapy. A 67 year-old female with inoperable...
Proton Therapy in NSCLC
11/11/2018
/
Publications
/
IMPT
Immunotherapy
A review on PBT for NSCLC. The review pointed out that despite early results suggesting improvements or at least comparable outcomes, the most recent randomized...
IBA Proton Therapy Conference at ASTRO 2019
15/09/2019
/
Event
/
Immunotherapy
ARC therapy
AMIT MAITY, MD, PhD Executive Vice-Chair Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia "Proton FLASH Radiation...
Combination therapy (protons/immunotherapy)
24/02/2023
/
Webinar
/
Immunotherapy
Jim Welsh explains how nanoparticles and proton therapy can address PD1 resistance. Step by step, he explains how to improve the synergy between radiotherapy...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.